Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Social Psychiatry and Psychiatric Epidemiology
Published in: Social Psychiatry and Psychiatric Epidemiology 4/2012

01-04-2012 | Original Paper

Treatment prevalence and incidence of schizophrenia in Quebec using a population health services perspective: different algorithms, different estimates

Authors: Alain Vanasse, Josiane Courteau, Marie-Josée Fleury, Jean-Pierre Grégoire, Alain Lesage, Jocelyne Moisan

Published in: Social Psychiatry and Psychiatric Epidemiology | Issue 4/2012

Login to get access

Abstract

Purpose

Using a population health services perspective, this article defines and assesses an efficient criteria-based algorithm to identify treatment prevalent and incident cases of schizophrenia. We refer here “treatment” prevalence and incidence since its evaluation depends on a patient receiving a health care service with a diagnosis of schizophrenia.

Methods

A population-based cohort study was conducted among all adults having a hospital discharge or a physician claim for schizophrenia in the public health plan databases between January 1996 and December 2006. Four algorithms to characterize patients with schizophrenia were defined. To identify treatment incident cases in 2006, we removed from the treatment prevalent pool patients with a previous record of schizophrenia between 1996 and 2006 (10-year clearance period). Using this 10-year period as reference, Kappa coefficients (KC) and positive predictive values (PPV) were calculated to determine the “optimal” length of clearance period to identify incident cases.

Results

The lifetime treatment prevalence and incidence of schizophrenia varied from 0.59 to 1.46% and from 42 to 94 per 100,000, respectively. When compared to the 10-year clearance period, the KC is excellent in a clearance period of 6–7 years. To achieve a PPV of 90%, a clearance period of 7–8 years would be necessary.

Conclusions

With an appropriate algorithm, treatment prevalence and incidence of schizophrenia can be conveniently estimated using administrative data. These estimates are a vital step toward appropriate planning of services for schizophrenia.
Literature
1.
Health Canada. A Report on Mental Illnesses in Canada. Ottawa, Canada 2002
2.
Hafner H, an der Heiden W (1997) Epidemiology of schizophrenia. Can J Psychiatry 42:139–151PubMed
3.
Goldner EM, Hsu L, Waraich P, Somers JM (2002) Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can J Psychiatry 47:833–843PubMed
4.
McGrath J, Saha S, Chant D, Welham J (2008) Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30:67–76PubMedCrossRef
5.
Saha S, Chant D, Welham J, McGrath J (2005) A systematic review of the prevalence of schizophrenia. PLOS Med 2(5):0413–0433CrossRef
6.
Arajärvi R, Suvisaari J, Suokas J, Schreck M, Haukka J, Hintikka J, Partonen T, Lönnqvist J et al (2005) Prevalence and diagnosis of schizophrenia based on register, case record and interview data in an isolated Finnish birth cohort born 1940–1969. Soc Psychiatry Psychiatr Epidemiol 40:808–816PubMedCrossRef
7.
Bray I, Waraich P, Jones W, Slater S, Goldner EM, Somers J (2006) Increase in schizophrenia incidence rates: findings in a Canadian cohort born 1975–1985. Soc Psychiatry Psychiatr Epidemiol 41:611–618PubMedCrossRef
8.
Drukker M, Krabbendam L, Driessen G, van Os J et al (2006) Social disadvantage and schizophrenia: a combined neighbourhood and individual-level analysis. Soc Psychiatry Psychiatr Epidemiol 41:595–604PubMedCrossRef
9.
Salokangas RKR, Helminen M, Koivisto AM, Rantanen H, Oja H, Pirkola S, Wahlbeck K, Joukamaa M (2010) Incidence of hospitalised schizophrenia in Finland since 1980: decreasing and increasing again. Soc Psychiatry Psychiatr Epidemiol (online first 20 March 2010)
10.
Valdes S, Botas P, Delgado E, Alvarez F, Cadorniga FD (2007) Population based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care 30(9):2258–2263PubMedCrossRef
11.
Brocco S, Visentin C, Fedeli U, Schievano E, Avogaro A, Andretta M, Avossa F, Spolaore P (2007) Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases. Cardiovasc Diabetol. doi:10.​1186/​1475-2840-6-5
12.
Sorensen HT, Sabroe S, Olsen J (1996) A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol 25(2):435–442PubMedCrossRef
13.
Rawson NS, Malcolm E, D’Arcy C (1997) Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol 32:191–199
14.
Lix LM, Yogendran M, Burchill C, Metge C, McKeen N, Moore D, Bond R (2006) Defining and validating chronic diseases: an administrative data approach. University of Manitoba, Manitoba Centre for Health Policy
15.
16.
Goldner EM, Jones W, Waraich P (2002) Using administrative data to analyse the prevalence and distribution of schizophrenic disorders. Psychiatr Serv 54(7):1017–1021CrossRef
17.
Asghari S, Courteau J, Carpentier AC, Vanasse A (2009) Optimal strategy to identify incidence of diagnostic of diabetes using administrative data. BMC Med Res Methodol. doi:10.​1186/​1471-2288-9-62
18.
Blanchard JF, Ludwig S, Wajda A, Dean H, Anderson K, Kendall O, Depew N (1996) Incidence and prevalence of diabetes in Manitoba, 1986–1991. Diabetes Care 19(8):807–811PubMedCrossRef
19.
Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM (1999) Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14(6):270–277PubMedCrossRef
20.
Hux JE, Ivis F, Flintoft V, Bica A (2002) Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25(3):512–516PubMedCrossRef
21.
22.
23.
24.
Hosmer DW, Lemeshow S (1999) Applied survival analysis: regression modeling of time to event data. Wiley Series in Probability and Statistics, New York
25.
SAS Institute Inc: SAS Version 9.2. 2002–2008
26.
27.
Newcombe Robert G (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857–872PubMedCrossRef
28.
29.
Chen CN, Wong J, Lee N, Chan-Ho M-W, Lau JT, Fung M (1993) The Shatin Community mental health survey in Hong Kong. Arch Gen Psychiatry 50:125–133PubMedCrossRef
30.
Canino GJ, Bird HR, Shrout PE, Rubio-Stipec M, Bravo M, Martinez R et al (1987) The prevalence of specific psychiatric disorders in Puerto Rico. Arch Gen Psychiatry 44:727–735PubMedCrossRef
31.
Iacono WG, Beiser M (1992) Are males more likely than females to develop schizophrenia? Am J Psychiatry 149:1070–1074PubMed
32.
King M, Coker E, Leavey G, Hoare A, Johnson-Sabine E (1994) Incidence of psychotic illness in London: comparison of ethnic groups. BMJ 309:1115–1119PubMedCrossRef
33.
Ouadahi Y, Lesage A, Rodrigue J, Fleury MJ (2009) Les problèmes de santé mentale sont-ils détectés par les omnipraticiens ? Regard sur la perspective des omnipraticiens selon les banques de données administratives. Santé mentale au Québec 34(1):161–172PubMed
34.
L’utilisation des services de santé mentale par les Montréalais en 2004-2005. Carrefour montréalais d’information sociosanitaire, Agence de la santé et des services sociaux de Montréal, 2007
35.
Nicole L, Lesage A, Lalonde P (1992) Lower incidence and increased male:Female ratio in schizophrenia. Br J Psychiatr 161:556–557CrossRef
36.
Saha S, Barendregt JJ, Vos T, Whiteford H, McGrath J et al (2008) Modelling disease frequency measures in schizophrenia epidemiology. Schizophr Res 104:246–254PubMedCrossRef
37.
38.
Carpentier N, Dorvil H, Lesage AD (1991) Utilization of out-patient services by first and second generation Italian immigrants and French Canadian patients with previous psychiatric hospitalizations. Santé Culture Health 8(3):285–305
39.
Aleman A, Kahn RS, Selten JP (2003) Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry 60:565–571PubMedCrossRef
40.
U.S. Department of Health and Human Services (1999) Mental health: a report of the surgeon general. Rockville, MD, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health
41.
Castle DJ, Murray RM (1993) The epidemiology of late-onset schizophrenia. Schizophr Bull 19(4):691–700PubMed
42.
Lipscombe LL, Hux JE (2007) Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet 369(9563):750–756PubMedCrossRef
43.
Martens P, Fransoo R, McKeen N, Burland E, Jebamani L, Burchill C, De Coster C, Ekuma O, Prior H, Chateau D, Robinson R, Metge C (2004) Patterns of regional mental illness disorder diagnoses and service use in Manitoba: a population based study. University of Manitoba, Manitoba Centre for Health Policy
44.
Fransoo R, Martens P, Burland E, The Need to Know Team, Prior H, Burchill C (2009) Manitoba RHA Indicators Atlas 2009. Manitoba Centre for Health Policy, Winnipeg
45.
Lix LM, DeVerteuil G, Walker JR, Robinson JR, Hinds AM, Roos LL (2007) Residential mobility of individuals with diagnosed schizophrenia: a comparison of single and multiple movers. Soc Psychiatry Psychiatr Epidemiol 42(3):221–228PubMedCrossRef
46.
Dalman CH, Broms J, Cullberg J, Allebeck P (2002) Young cases of schizophrenia identified in a national inpatient register: are the diagnoses valid? Soc Psychiatry Psychiatr Epidemiol 37:527–531PubMedCrossRef
47.
Lesage AD, Tansella M (1989) Mobility of schizophrenic patients, non-psychotic patients and the general population in a case register area. Social Psychiatry Psychiatr Epidemiol 24:271–274CrossRef
48.
Bernard A, Finnie R, St-Jean B. Interprovincial mobility and earnings. October 2008 Perspectives. Statistics Canada—Catalogue no. 75-001-X
Metadata
Title
Treatment prevalence and incidence of schizophrenia in Quebec using a population health services perspective: different algorithms, different estimates
Authors
Alain Vanasse
Josiane Courteau
Marie-Josée Fleury
Jean-Pierre Grégoire
Alain Lesage
Jocelyne Moisan
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Social Psychiatry and Psychiatric Epidemiology / Issue 4/2012
Print ISSN: 0933-7954
Electronic ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-011-0371-y

Other articles of this Issue 4/2012

Social Psychiatry and Psychiatric Epidemiology 4/2012 Go to the issue

Original Paper

Cognitive function and competitive employment in schizophrenia: relative contribution of insight and psychopathology

Original Paper

Family burden and functional assessment in the Swedish CLIPS-study: do staff and relatives agree on individuals with psychotic disorders’ functional status?

Original Paper

A semi-structured clinical interview for psychosis sub-groups (SCIPS): development and psychometric properties

Original Paper

Mental health consumers and caregivers as instructors for health professional students: a qualitative study

Original Paper

Depressive symptoms and suicide in 56,000 older Chinese: a Hong Kong cohort study

Original Paper

Gender differences in insomnia and the role of paid work and family responsibilities